Search Results - "Opioid receptors"

This result is not displayed to guests.
Login for full access.

Autonomic nervous system modulation by G protein-biased mu-opioid receptor agonists: A translational scoping review protocol.

Authors: Zhang, Yi Chen, Qiuxiang Zhou, Yuanyuan et al.

Source: PLoS ONE. 5/15/2026, Vol. 21 Issue 5, p1-10. 10p.

Receptor Binding, Functional Activity, and Cell Viability Assessment of Novel Marine-Based Hybrid Peptides from Raja porosa.

Authors: Bauer, Marta Szeleszczuk, Łukasz Velmurugan, Bharath Kumar et al.

Source: Marine Drugs. May2026, Vol. 24 Issue 5, p181. 20p.

Persistent Mu-Opioid Receptor Dysregulation in a Pain-Facilitatory Brain Region Reinstates Hyperalgesia After Resolution of Opioid-Induced Hyperalgesia.

Authors: Sousa, Marília Costa, Ana Rita Tavares, Isaura et al.

Source: Pharmaceuticals (14248247). May2026, Vol. 19 Issue 5, p695. 19p.

Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair.

Authors: Perlikowska, Renata Domowicz, Małgorzata Śliwińska, Agnieszka et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 9, p4122. 30p.

Venlafaxine as Monotherapy and in Combination Regimens in Acute Rodent Nociception Experimental Models: A Review.

Authors: Lungu, Cristina Marin, Ruxandra-Cristina Costescu, Mihnea et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 9, p3944. 17p.

Kappa-Opioid Receptor Antagonism Prolongs the Antidepressant Effects of Ketamine in Adult Mice with Depression-like Behavior Induced by Adolescent Chronic Unpredictable Stress.

Authors: Zivanovic, Ana Mitic, Milos Lukic, Iva et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 6, p2815. 22p.

Opioids regulate the functional state of immune cells and reduce inflammatory cardiac injury: Role of opioid receptors, MRGPRX2, and TLR4.

Authors: Gusakova, Svetlana V. Sirotina, Maria Maslov, Leonid N. et al.

Source: Journal of Biomedical Research. Mar2026, Vol. 40 Issue 2, p105-119. 15p.

Indole Alkaloids as Biased Opioid Receptor Modulators.

Authors: Grundmann, Oliver Henderson, Allison

Source: Pharmaceuticals (14248247). Mar2026, Vol. 19 Issue 3, p397. 12p.

Identification of Neferine as a DOR Agonist Activating G i and G z Signaling: In Silico and In Vitro Studies.

Authors: Bi, Zenghao Liang, Yuting Tang, Xinyu et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 4, p2058. 14p.

Analgesic and Antidiarrheal Properties of Lappaconitine, Possibly Through Cyclooxygenase and µ‐Opioid Receptor Interaction Pathways: In Vivo and In Silico Studies.

Authors: Shah, Shahid Akter, Arifa Sheikh, Salehin et al.

Source: Immunity, Inflammation & Disease. Feb2026, Vol. 14 Issue 2, p1-14. 14p.

Efficacy and safety of μ1-opioid receptor agonist (Taphalgin®) for emergency analgesia in outpatient practice.

Authors: Voloshin, Alexey G. Avetisova, Kseniya N. Smirnova, Natal'ya V.

Source: Saudi Journal of Anaesthesia. Jan-Mar2026, Vol. 20 Issue 1, p23-26. 4p.

Peripheral Analgesic Effect of a Novel Curcuminoid Derivative: Possible Involvement of Peripheral Opioid Receptor and ATP-Sensitive Potassium Ion Channel.

Authors: Lee, Ming Tatt Ho, Yu-Cheng Tham, Chau Ling et al.

Source: Pharmaceutics. Jan2026, Vol. 18 Issue 1, p141. 13p.

This result is not displayed to guests.
Login for full access.

Possible Involvement of Hallucinogenic Effects in the Aversive Effects Induced by Kappa‐Opioid and 5‐HT2A/2C Receptor Agonists in Mice.

Authors: Kato, Hideaki Ichimaru, Yoshimi Kurihara, Masaaki et al.

Source: Neuropsychopharmacology Reports. Dec2025, Vol. 45 Issue 4, p1-9. 9p.

Rapid‐Onset Therapeutic Effects of Delta Opioid Receptor Agonists on Depression‐Like Behaviors Induced by Chronic Social Defeat Stress.

Authors: Tokuda, Akihisa Nagumo, Yasuyuki Kajino, Keita et al.

Source: Neuropsychopharmacology Reports. Dec2025, Vol. 45 Issue 4, p1-14. 14p.

Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitis.

Authors: Denny, Lisa Robichon, Katharina Templeton, Nikki et al.

Source: Clinical & Translational Immunology. 2025, Vol. 14 Issue 12, p1-16. 16p.

Design, synthesis, and pharmacological profiling of cyclic tetra-peptide derivatives for opioid receptor modulation: a review.

Authors: Oyebamiji, Abel Kolawole Akintelu, Sunday A. Olujinmi, Faith Eniola et al.

Source: Discover Molecules (3004-9350). Dec2025, Vol. 2 Issue 1, p1-28. 28p.

MBD1-dependent recruitment of SUV39h1 induces H3K9me3-mediated transcriptional silencing of Oprm1 in dorsal root ganglia after peripheral nerve injury.

Authors: Sheng, Hengwei Gong, Hualei Liu, Xiaolin et al.

Source: Molecular Pain. 10/15/2025, Vol. 21, p1-12. 12p.

κ-Opioid Receptor Agonists as Robust Pain-Modulating Agents: Mechanisms and Therapeutic Potential in Pain Modulation.

Authors: García-Domínguez, Mario^1,2,3 (AUTHOR)

Source: Journal of Clinical Medicine. Oct2025, Vol. 14 Issue 20, p7263. 28p.